P53 GENE ANALYSIS OF OVARIAN BORDERLINE TUMORS AND STAGE-I CARCINOMAS

被引:68
作者
KUPRYJANCZYK, J
BELL, DA
DIMEO, D
BEAUCHAMP, R
THOR, AD
YANDELL, DW
机构
[1] HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115
[2] MASSACHUSETTS GEN HOSP,JAMES HOMER WRIGHT PATHOL LABS,BOSTON,MA 02114
[3] HARVARD UNIV,SCH PUBL HLTH,DEPT CANC BIOL,BOSTON,MA 02115
[4] UNIV VERMONT,DEPT PATHOL,BURLINGTON,VT 05405
关键词
P53; GENE; OVARY; BORDERLINE TUMORS; EARLY OVARIAN CANCER; CLONALITY;
D O I
10.1016/0046-8177(95)90138-8
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Mutations of the p53 gene are common in human ovarian carcinomas; however, their role in the early development of ovarian cancer is unclear. Twelve ovarian borderline tumors (BTs; eight of them p53 immunopositive) and 10 stage I carcinomas (four of them p53 immunopositive) were studied for genetic alterations in the p53 gene. The study was based on single-strand conformation polymorphism (SSCP) analysis and DNA sequencing of exons 2 through 11 of the p53 gene using DNA preparations from microdissected tumors. Mutations were found in 40% of the carcinomas (including a borderline component adjacent to carcinoma in one lesion) but in none of the pure BTs. These findings suggest that p53 mutations may not be commonly associated with the borderline phenotype of ovarian epithelial tumors but may occur during malignant transformation. HUM PATHOL 26:387-392. Copyright (C) 1995 by W.B. Saunders Company
引用
收藏
页码:387 / 392
页数:6
相关论文
共 29 条
[1]   ABNORMAL EXPRESSION OF WILD TYPE-P53 PROTEIN IN NORMAL-CELLS OF A CANCER FAMILY PATIENT [J].
BARNES, DM ;
HANBY, AM ;
GILLETT, CE ;
MOHAMMED, S ;
HODGSON, S ;
BOBROW, LG ;
LEIGH, IM ;
PURKIS, T ;
MACGEOCH, C ;
SPURR, NK ;
BARTEK, J ;
VOJTESEK, B ;
PICKSLEY, SM ;
LANE, DP .
LANCET, 1992, 340 (8814) :259-263
[2]  
BELL DA, 1988, CANCER, V62, P2212, DOI 10.1002/1097-0142(19881115)62:10<2212::AID-CNCR2820621024>3.0.CO
[3]  
2-W
[4]   OVARIAN SEROUS BORDERLINE TUMORS WITH STROMAL MICROINVASION - A REPORT OF 21 CASES [J].
BELL, DA ;
SCULLY, RE .
HUMAN PATHOLOGY, 1990, 21 (04) :397-403
[5]  
FRITSCHE M, 1993, ONCOGENE, V8, P307
[6]   CLONAL ORIGIN OF EPITHELIAL OVARIAN-CARCINOMA - ANALYSIS BY LOSS OF HETEROZYGOSITY, P53-MUTATION, AND X-CHROMOSOME INACTIVATION [J].
JACOBS, IJ ;
KOHLER, MF ;
WISEMAN, RW ;
MARKS, JR ;
WHITAKER, R ;
KERNS, BAJ ;
HUMPHREY, P ;
BERCHUCK, A ;
PONDER, BAJ ;
BAST, RC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (23) :1793-1798
[7]   REDUCTION OF P53 GENE DOSAGE DOES NOT INCREASE INITIATION OR PROMOTION BUT ENHANCES MALIGNANT PROGRESSION OF CHEMICALLY-INDUCED SKIN TUMORS [J].
KEMP, CJ ;
DONEHOWER, LA ;
BRADLEY, A ;
BALMAIN, A .
CELL, 1993, 74 (05) :813-822
[8]  
KOHLER MF, 1993, OBSTET GYNECOL, V81, P643
[9]   SPECTRUM OF MUTATION AND FREQUENCY OF ALLELIC DELETION OF THE P53 GENE IN OVARIAN-CANCER [J].
KOHLER, MF ;
MARKS, JR ;
WISEMAN, RW ;
JACOBS, IJ ;
DAVIDOFF, AM ;
CLARKEPEARSON, DL ;
SOPER, JT ;
BAST, RC ;
BERCHUCK, A .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (18) :1513-1519
[10]  
KOTTMEITER HL, 1979, ANN REPORT TREATMENT, V17